323 related articles for article (PubMed ID: 22338037)
1. Choline intake in a large cohort of patients with nonalcoholic fatty liver disease.
Guerrerio AL; Colvin RM; Schwartz AK; Molleston JP; Murray KF; Diehl A; Mohan P; Schwimmer JB; Lavine JE; Torbenson MS; Scheimann AO
Am J Clin Nutr; 2012 Apr; 95(4):892-900. PubMed ID: 22338037
[TBL] [Abstract][Full Text] [Related]
2. Correlation of vitamin E, uric acid, and diet composition with histologic features of pediatric NAFLD.
Vos MB; Colvin R; Belt P; Molleston JP; Murray KF; Rosenthal P; Schwimmer JB; Tonascia J; Unalp A; Lavine JE;
J Pediatr Gastroenterol Nutr; 2012 Jan; 54(1):90-6. PubMed ID: 22197855
[TBL] [Abstract][Full Text] [Related]
3. Higher dietary choline intake is associated with lower risk of nonalcoholic fatty liver in normal-weight Chinese women.
Yu D; Shu XO; Xiang YB; Li H; Yang G; Gao YT; Zheng W; Zhang X
J Nutr; 2014 Dec; 144(12):2034-40. PubMed ID: 25320186
[TBL] [Abstract][Full Text] [Related]
4. Estimation of fish and ω-3 fatty acid intake in pediatric nonalcoholic fatty liver disease.
St-Jules DE; Watters CA; Brunt EM; Wilkens LR; Novotny R; Belt P; Lavine JE;
J Pediatr Gastroenterol Nutr; 2013 Nov; 57(5):627-33. PubMed ID: 24177784
[TBL] [Abstract][Full Text] [Related]
5. In Children With Nonalcoholic Fatty Liver Disease, Zone 1 Steatosis Is Associated With Advanced Fibrosis.
Africa JA; Behling CA; Brunt EM; Zhang N; Luo Y; Wells A; Hou J; Belt PH; Kohil R; Lavine JE; Molleston JP; Newton KP; Whitington PF; Schwimmer JB;
Clin Gastroenterol Hepatol; 2018 Mar; 16(3):438-446.e1. PubMed ID: 28286193
[TBL] [Abstract][Full Text] [Related]
6. Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease.
Patton HM; Yates K; Unalp-Arida A; Behling CA; Huang TT; Rosenthal P; Sanyal AJ; Schwimmer JB; Lavine JE
Am J Gastroenterol; 2010 Sep; 105(9):2093-102. PubMed ID: 20372110
[TBL] [Abstract][Full Text] [Related]
7. Haptoglobin Genotype and Vitamin E Versus Placebo for the Treatment of Nondiabetic Patients with Nonalcoholic Steatohepatitis in China: A Multicenter, Randomized, Placebo-Controlled Trial Design.
Zang S; Chen J; Song Y; Bai L; Chen J; Chi X; He F; Sheng H; Wang J; Xie S; Xie W; Yang Y; Zhang J; Zheng M; Zou Z; Wang B; Shi J;
Adv Ther; 2018 Feb; 35(2):218-231. PubMed ID: 29411270
[TBL] [Abstract][Full Text] [Related]
8. ADH1B∗2 Is Associated With Reduced Severity of Nonalcoholic Fatty Liver Disease in Adults, Independent of Alcohol Consumption.
Vilar-Gomez E; Sookoian S; Pirola CJ; Liang T; Gawrieh S; Cummings O; Liu W; Chalasani NP
Gastroenterology; 2020 Sep; 159(3):929-943. PubMed ID: 32454036
[TBL] [Abstract][Full Text] [Related]
9. Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy.
Alqahtani A; Elahmedi M; Alswat K; Arafah M; Fagih M; Lee J
Surg Obes Relat Dis; 2017 Sep; 13(9):1599-1609. PubMed ID: 28600116
[TBL] [Abstract][Full Text] [Related]
10. Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease.
Kleiner DE; Brunt EM; Wilson LA; Behling C; Guy C; Contos M; Cummings O; Yeh M; Gill R; Chalasani N; Neuschwander-Tetri BA; Diehl AM; Dasarathy S; Terrault N; Kowdley K; Loomba R; Belt P; Tonascia J; Lavine JE; Sanyal AJ;
JAMA Netw Open; 2019 Oct; 2(10):e1912565. PubMed ID: 31584681
[TBL] [Abstract][Full Text] [Related]
11. Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network.
Brunt EM; Kleiner DE; Wilson LA; Unalp A; Behling CE; Lavine JE; Neuschwander-Tetri BA;
Hepatology; 2009 Mar; 49(3):809-20. PubMed ID: 19142989
[TBL] [Abstract][Full Text] [Related]
12. A cross-sectional study assessing dietary intake and physical activity in Canadian patients with nonalcoholic fatty liver disease vs healthy controls.
Da Silva HE; Arendt BM; Noureldin SA; Therapondos G; Guindi M; Allard JP
J Acad Nutr Diet; 2014 Aug; 114(8):1181-94. PubMed ID: 24631112
[TBL] [Abstract][Full Text] [Related]
13. Ethnicity and nonalcoholic fatty liver disease.
Bambha K; Belt P; Abraham M; Wilson LA; Pabst M; Ferrell L; Unalp-Arida A; Bass N;
Hepatology; 2012 Mar; 55(3):769-80. PubMed ID: 21987488
[TBL] [Abstract][Full Text] [Related]
14. Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort.
Harrison SA; Gawrieh S; Roberts K; Lisanti CJ; Schwope RB; Cebe KM; Paradis V; Bedossa P; Aldridge Whitehead JM; Labourdette A; Miette V; Neubauer S; Fournier C; Paredes AH; Alkhouri N
J Hepatol; 2021 Aug; 75(2):284-291. PubMed ID: 33746083
[TBL] [Abstract][Full Text] [Related]
15. Generalizability of the nonalcoholic steatohepatitis Clinical Research Network histologic scoring system for nonalcoholic fatty liver disease.
Juluri R; Vuppalanchi R; Olson J; Unalp A; Van Natta ML; Cummings OW; Tonascia J; Chalasani N
J Clin Gastroenterol; 2011 Jan; 45(1):55-8. PubMed ID: 20505526
[TBL] [Abstract][Full Text] [Related]
16. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
[TBL] [Abstract][Full Text] [Related]
17. Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors.
Leite NC; Villela-Nogueira CA; Pannain VL; Bottino AC; Rezende GF; Cardoso CR; Salles GF
Liver Int; 2011 May; 31(5):700-6. PubMed ID: 21457442
[TBL] [Abstract][Full Text] [Related]
18. Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease.
Kistler KD; Brunt EM; Clark JM; Diehl AM; Sallis JF; Schwimmer JB;
Am J Gastroenterol; 2011 Mar; 106(3):460-8; quiz 469. PubMed ID: 21206486
[TBL] [Abstract][Full Text] [Related]
19. Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women.
Hamaguchi M; Kojima T; Ohbora A; Takeda N; Fukui M; Kato T
World J Gastroenterol; 2012 Jan; 18(3):237-43. PubMed ID: 22294826
[TBL] [Abstract][Full Text] [Related]
20. Biopsy rate and nonalcoholic steatohepatitis (NASH) in patients with nonalcoholic fatty liver disease (NAFLD).
Gerhardt F; Petroff D; Blank V; Böhlig A; van Bömmel F; Wittekind C; Berg T; Karlas T; Wiegand J
Scand J Gastroenterol; 2020 Jun; 55(6):706-711. PubMed ID: 32476514
[No Abstract] [Full Text] [Related]
[Next] [New Search]
